Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2014
04/17/2014WO2012118717A3 Coupling endonucleases with end-processing enzymes drive high efficiency gene disruption
04/17/2014WO2012109430A3 Pesticidal nucleic acids and proteins and uses thereof
04/17/2014US20140109263 USE OF Cry1Ea IN COMBINATIONS FOR MANAGEMENT OF RESISTANT FALL ARMYWORM INSECTS
04/17/2014US20140109261 Plant regulatory elements and uses thereof
04/17/2014US20140109260 In vivo Assembly of Transcription Units
04/17/2014US20140109259 Guard Cell Promoters and Uses Thereof
04/17/2014US20140109258 Rna constructs
04/17/2014US20140109256 Glyphosate-tolerant wheat genotypes
04/17/2014US20140109255 Soybean Cultivar 131TD735
04/17/2014US20140109252 Melon variety nun 26191 mem
04/17/2014US20140109251 Melon variety nun 26171 mem
04/17/2014US20140109249 Screening methods
04/17/2014US20140109248 New cultivar, method for differentiating plant cultivars, and method for causing earlier maturing of rice individual
04/17/2014US20140109247 Rat embryonic stem cell
04/17/2014US20140107330 Oligomeric compounds comprising bicyclic nucleotides and uses thereof
04/17/2014US20140107190 Highly inducible dual-promoter lentiviral tet-on system
04/17/2014US20140107188 Use of hgma-targeted phosphorothioate dna aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells
04/17/2014US20140107187 Functional nucleic acid molecule and use thereof
04/17/2014US20140107186 Capsid-free aav vectors, compositions, and methods for vector production and gene delivery
04/17/2014US20140107185 Aav -vectors for use in gene therapy of choroideremia
04/17/2014US20140107184 Modulation of hepatitis b virus (hbv) expression
04/17/2014US20140107183 Microrna compounds and methods for modulating mir-21 activity
04/17/2014US20140107182 Synthetic mimics of mir-34
04/17/2014US20140107181 Methods and means for treatment of osteoarthritis
04/17/2014US20140107180 Modulation of androgen receptor expression
04/17/2014US20140107179 ORGANIC COMPOSITIONS TO TREAT Beta-ENaC-RELATED DISEASES
04/17/2014US20140107178 Methods and compositions for the specific inhibition of myc by double-stranded rna
04/17/2014US20140107013 Compound and method for treating myotonic dystrophy
04/17/2014US20140106978 Automatic Threshold Setting and Baseline Determination for Real-Time PCR
04/17/2014US20140106458 Conjugative Plasmids and Methods of Use Thereof
04/17/2014US20140106457 Stably maintained multiple copies of at least two ORF in the same orientation
04/17/2014US20140106456 Apparatus for introducing biological material, method of introducing biological material and magnetic support for introducing biological material
04/17/2014US20140106451 Substituted 2'-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
04/17/2014US20140106450 Compositions and Methods for Inhibiting Expression of a Target Gene
04/17/2014US20140106417 Dgat genes and methods of use for triglyceride production in recombinant microorganisms
04/17/2014US20140106416 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
04/17/2014US20140106398 Vector-host system
04/17/2014US20140106351 Methods and systems for identifying micro-rna targets and synthesizing novel micro-rnas and uses of the same
04/17/2014US20140106347 Binding interactions in dipstick assays
04/17/2014US20140106341 Stabilized bioactive peptides and methods of identification, synthesis, and use
04/17/2014US20140105966 Modified polynucleotides encoding hepatitis a virus cellular receptor 2
04/17/2014US20140105965 Modified polynucleotides encoding copper metabolism (murr1) domain containing 1
04/17/2014US20140105912 Vista modulators for diagnosis and treatment of cancer
04/17/2014US20140105873 Agents useful in treating facioscapulohumeral muscular dystrophy
04/17/2014US20140105869 Compositions and Methods for Treating Musculoskeletal Diseases and Disorders
04/17/2014US20140105863 Polycistronic expression system for bacteria
04/16/2014EP2719774A1 Methods of monitoring conditions by sequence analysis
04/16/2014EP2719772A1 Method for detecting fungi, reaction solution for pcr, and carrier for detecting fungi
04/16/2014EP2719765A1 Ex vivo method for inserting nucleic acids in cells
04/16/2014EP2719764A2 Expression vector for animal cells including csp-b 5'-sar factor and method for producing recombinant proteins using same
04/16/2014EP2719763A1 Heterodimeric transcription factor involved in PSK synthesis
04/16/2014EP2719762A1 Tyrosinase inhibitors for depigmentation or hair removal
04/16/2014EP2719761A1 Flavin-binding glucose dehydrogenase, method for manufacturing flavin-binding glucose dehydrogenase, and glucose measurement method using same
04/16/2014EP2719760A1 Improved nitrile hydratase
04/16/2014EP2719759A1 Production method for artificial cancer stem cell and induced differentiation method therefor
04/16/2014EP2719757A1 Production of secreted bioproducts from photosynthetic microbes
04/16/2014EP2718486A2 Methods and compositions of predicting activity of retinoid x receptor modulator
04/16/2014EP2718462A1 Method for predicting the response to treatment with an her2-blocking agent
04/16/2014EP2718446A2 Improved recombination efficiency by inhibition of nhej dna repair
04/16/2014EP2718445A2 A simple two plasmid mammalian expression system for production of recombinant proteins and viruses
04/16/2014EP2718444A1 In vivo de-glycosylation of recombinant proteins by co-expression with pngase f
04/16/2014EP2718443A1 Methods and means to modify a plant genome at a preselected site
04/16/2014EP2718442A1 Genetic manipulation and expression systems for pucciniomycotina and ustilaginomycotina subphyla
04/16/2014EP2718441A1 Multiple interferon and virus response element cell-based fluorescence system
04/16/2014EP2718440A1 Protein having nuclease activity, fusion proteins and uses thereof
04/16/2014EP2718439A1 Treatment of frataxin (fxn) related diseases by inhibition of natural antisense transcript to fxn
04/16/2014EP2718438A1 Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy
04/16/2014EP2718437A1 Methods for the treatment of leber congenital amaurosis
04/16/2014EP2718436A1 Materials and methods for treating pten mutated or deficient cancer
04/16/2014EP2718435A1 Sema5b peptides and vaccines including the same
04/16/2014EP2718434A2 Compositions and methods for treating celiac sprue disease
04/16/2014EP2718432A1 Nuclease fusion protein and uses thereof
04/16/2014EP2718429A1 Infectious clones of torque teno virus
04/16/2014EP2718428A1 Rabies virus like particle production in plants
04/16/2014EP2718427A1 Compositions and methods for glioblastoma treatment
04/16/2014EP2718328A1 Compositions and methods for increasing serum half-life
04/16/2014EP2718321A1 Anti-ricin antibodies and uses thereof
04/16/2014EP2718319A1 Hepatocyte based insulin gene therapy for diabetes
04/16/2014EP2718309A1 Transcription factor modulating terpene biosynthesis
04/16/2014EP2717883A1 Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (arg)
04/16/2014EP2717675A2 Hybrid tomatoes and methods of making hybrid tomatoes
04/16/2014CN103732753A Recombinant production of steviol glycosides
04/16/2014CN103732752A Constructs and method for regulating gene expression or for detecting and controlling a DNA locus in eukaryotes
04/16/2014CN103732751A Gene expression and eradication system in helicobacter pylori
04/16/2014CN103732750A Immunogenic composition
04/16/2014CN103732749A Computationally optimized broadly reactive antigens for H1N1 influenza
04/16/2014CN103732748A Production method for nucleic acid aptamer
04/16/2014CN103732747A Method for identification and isolation of terminator sequences causing enhanced transcription
04/16/2014CN103732746A Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
04/16/2014CN103732745A Identifying markers of caloric restriction and caloric restriction mimetics
04/16/2014CN103732744A Methods for preparative in vitro cloning
04/16/2014CN103732743A Mphosph1 peptides and vaccines including the same
04/16/2014CN103732742A Hydrogen peroxide resistance-imparting gene and method for using same
04/16/2014CN103732735A Recombinant bacteria having improved sucrose utilization
04/16/2014CN103732615A Use of jaz5A for improving drought-resistance in a plant
04/16/2014CN103732236A Methods and compositions for production of vaccina virus
04/16/2014CN103732055A Plants having enhanced yield-related traits and a method for making the same
04/16/2014CN103728458A Applications of rabbit encephalitozoon cuniculi spore wall protein SWP1 to preparation of reagent for diagnosing or detecting rabbit encephalitozoon cuniculi infection
04/16/2014CN103725801A Amphimorphic RT-PCR (Reverse Transcription-Polymerase Chain Reaction) detection kit of duck flavivirus and duck circovirus
04/16/2014CN103725798A Primer, kit and detection method of detecting haemorrhagic fever with renal syndrome virus by RT-LAMP (Reverse Transcription Loop-Mediated Isothermal Amplification) method